Stay updated on Soticlestat in Rare Epilepsies Clinical Trial

Sign up to get notified when there's something new on the Soticlestat in Rare Epilepsies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Soticlestat in Rare Epilepsies Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now shows that ENDYMION 1 (NCT03635073) has been terminated, with the termination reason citing negative results from related trials and indicating that supplementary data is no longer necessary.
    Difference
    0.1%
    Check dated 2025-12-31T17:11:39.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The Locations section was revised to replace individual site entries with a consolidated list; new locations were added (e.g., Victoria, Ontario, Guangdong, Shanghai, Tel Aviv, Madrid, Navarre) while prior sites (Arizona, California, Colorado, etc.) were removed.
    Difference
    2%
    Check dated 2025-12-24T14:52:11.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The Endymion 1 study (NCT03635073) has been terminated and closed. Takeda states this was due to negative results from related SKYLINE and SKYWAY studies and that supplementary data from TAK-935-18-001 is no longer necessary.
    Difference
    0.1%
    Check dated 2025-12-17T03:05:08.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.2, replacing Revision: v3.2.0, with no changes to the trial details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T14:45:57.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Removed the notice about potential delays and updates due to a lapse in government funding and the NIH Clinical Center's operating status.
    Difference
    0.3%
    Check dated 2025-11-18T07:31:31.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The ENDYMION 1 study (NCT03635073) has been terminated and closed by the sponsor due to negative results from related phase 3 trials, and this termination is noted on the Study Details page.
    Difference
    0.1%
    Check dated 2025-11-11T03:36:03.000Z thumbnail image

Stay in the know with updates to Soticlestat in Rare Epilepsies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Soticlestat in Rare Epilepsies Clinical Trial page.